DARE - CIK 0001401914
Dare Bioscience, Inc. has filed 740 documents with the SEC between 2007 and 2026. The most frequent type is major company event (209 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Proxy statement | DEF 14A | 2024-04-26 | 2024-06-05 |
| Annual report to shareholders | ARS | 2024-04-26 | 2023-12-31 |
| PRE 14A | - | 2024-04-16 | 2024-06-05 |
| SEC correspondence | UPLOAD | 2024-04-03 | - |
| SEC correspondence | UPLOAD | 2024-04-03 | - |
| Securities registration | S-3 | 2024-03-29 | - |
| Securities registration | S-3 | 2024-03-29 | - |
| Major company event | 8-K | 2024-03-28 | 2024-03-28 |
| Prospectus supplement | 424B5 | 2024-03-28 | - |
| Annual report | 10-K | 2024-03-28 | 2023-12-31 |
| Insider trade | 4 | 2024-03-14 | 2024-03-12 |
| Insider trade | 4 | 2024-03-14 | 2024-03-12 |
| Insider trade | 4 | 2024-03-14 | 2024-03-12 |
| New insider ownership | 3 | 2024-01-29 | 2024-01-26 |
| Major company event | 8-K | 2024-01-26 | 2024-01-23 |
| Major company event | 8-K | 2024-01-19 | 2024-01-17 |
| Major company event | 8-K | 2024-01-08 | 2024-01-08 |
| D | - | 2023-12-26 | - |
| Major company event | 8-K | 2023-12-26 | 2023-12-21 |
| Major company event | 8-K | 2023-12-20 | 2023-12-20 |
| Major company event | 8-K | 2023-11-09 | 2023-11-09 |
| Major company event | 8-K | 2023-11-09 | 2023-11-09 |
| Quarterly report | 10-Q | 2023-11-09 | 2023-09-30 |
| Major company event | 8-K | 2023-11-01 | 2023-11-01 |
| Major company event | 8-K | 2023-10-16 | 2023-10-12 |
| Major company event | 8-K | 2023-09-11 | 2023-09-11 |
| Prospectus supplement | 424B5 | 2023-08-30 | - |
| Major company event | 8-K | 2023-08-30 | 2023-08-29 |
| Major company event | 8-K | 2023-08-10 | 2023-08-10 |
| Quarterly report | 10-Q | 2023-08-10 | 2023-06-30 |
| Major company event | 8-K | 2023-07-21 | 2023-07-19 |
| Major company event | 8-K | 2023-07-05 | 2023-07-04 |
| Major company event | 8-K | 2023-06-22 | 2023-06-21 |
| Insider trade | 4 | 2023-06-21 | 2023-06-21 |
| Insider trade | 4 | 2023-06-21 | 2023-06-21 |
| Insider trade | 4 | 2023-06-21 | 2023-06-21 |
| Insider trade | 4 | 2023-06-21 | 2023-06-21 |
| Insider trade | 4 | 2023-06-21 | 2023-06-21 |
| Insider trade | 4 | 2023-06-21 | 2023-06-21 |
| Insider trade | 4 | 2023-06-21 | 2023-06-21 |
| Major company event | 8-K | 2023-06-05 | 2023-06-05 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Annual report to shareholders | ARS | 2023-05-01 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-04-27 | - |
| Proxy statement | DEF 14A | 2023-04-27 | 2023-06-21 |
| Prospectus supplement | 424B5 | 2023-03-31 | - |
| Major company event | 8-K | 2023-03-31 | 2023-03-31 |
| Major company event | 8-K | 2023-03-30 | 2023-03-30 |
| Annual report | 10-K | 2023-03-30 | 2022-12-31 |